Core Laboratories (NYSE:CLB) Updates Q1 2026 Earnings Guidance

Core Laboratories (NYSE:CLB) issued an update on its first quarter 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 0.110-0.150 for the period, compared to the consensus earnings per share estimate of 0.160. The company issued revenue guidance of $124.0 million-$130.0 million, compared to the consensus revenue estimate of $129.5 million.

Core Laboratories Price Performance

Shares of NYSE:CLB traded down $0.03 on Wednesday, reaching $19.61. 332,790 shares of the company traded hands, compared to its average volume of 349,864. The stock has a market capitalization of $913.04 million, a PE ratio of 29.27, a P/E/G ratio of 17.09 and a beta of 1.09. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.37 and a quick ratio of 1.76. The company’s 50 day moving average is $17.52 and its 200-day moving average is $14.37. Core Laboratories has a fifty-two week low of $9.72 and a fifty-two week high of $20.36.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “hold (c)” rating on shares of Core Laboratories in a research report on Monday, December 29th. Four research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Core Laboratories currently has a consensus rating of “Hold” and an average target price of $12.50.

Hedge Funds Weigh In On Core Laboratories

Several institutional investors and hedge funds have recently made changes to their positions in the company. Disciplined Growth Investors Inc. MN increased its stake in Core Laboratories by 9.7% in the third quarter. Disciplined Growth Investors Inc. MN now owns 5,969,860 shares of the oil and gas company’s stock valued at $73,787,000 after acquiring an additional 528,976 shares during the last quarter. Bank of America Corp DE raised its holdings in shares of Core Laboratories by 48.1% during the 3rd quarter. Bank of America Corp DE now owns 343,340 shares of the oil and gas company’s stock worth $4,244,000 after buying an additional 111,527 shares in the last quarter. Hotchkis & Wiley Capital Management LLC boosted its stake in Core Laboratories by 22.2% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 559,625 shares of the oil and gas company’s stock valued at $6,917,000 after buying an additional 101,755 shares in the last quarter. BNP Paribas Financial Markets boosted its stake in Core Laboratories by 1,667.2% in the third quarter. BNP Paribas Financial Markets now owns 79,628 shares of the oil and gas company’s stock valued at $984,000 after buying an additional 75,122 shares in the last quarter. Finally, Balyasny Asset Management L.P. acquired a new position in Core Laboratories during the second quarter worth about $586,000. Institutional investors and hedge funds own 97.81% of the company’s stock.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.